X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS IPCA LABS DR. DATSONS LABS/
IPCA LABS
 
P/E (TTM) x -10.9 36.7 - View Chart
P/BV x 0.2 3.5 4.7% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 DR. DATSONS LABS   IPCA LABS
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
IPCA LABS
Mar-17
DR. DATSONS LABS/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs126643 19.5%   
Low Rs31503 6.1%   
Sales per share (Unadj.) Rs133.0254.4 52.3%  
Earnings per share (Unadj.) Rs0.216.1 0.9%  
Cash flow per share (Unadj.) Rs6.629.8 22.2%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs128.8194.6 66.2%  
Shares outstanding (eoy) m31.66126.20 25.1%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.62.3 26.1%   
Avg P/E ratio x516.135.7 1,447.7%  
P/CF ratio (eoy) x11.819.2 61.5%  
Price / Book Value ratio x0.62.9 20.6%  
Dividend payout %06.2 0.0%   
Avg Mkt Cap Rs m2,47772,300 3.4%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m566,960 0.8%   
Avg. sales/employee Rs ThNM2,413.5-  
Avg. wages/employee Rs ThNM523.2-  
Avg. net profit/employee Rs ThNM152.4-  
INCOME DATA
Net Sales Rs m4,21132,106 13.1%  
Other income Rs m79226 34.9%   
Total revenues Rs m4,28932,332 13.3%   
Gross profit Rs m5694,448 12.8%  
Depreciation Rs m2041,730 11.8%   
Interest Rs m430241 178.7%   
Profit before tax Rs m132,703 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6675 0.9%   
Profit after tax Rs m52,028 0.2%  
Gross profit margin %13.513.9 97.5%  
Effective tax rate %48.025.0 192.3%   
Net profit margin %0.16.3 1.8%  
BALANCE SHEET DATA
Current assets Rs m6,85217,340 39.5%   
Current liabilities Rs m6,7119,559 70.2%   
Net working cap to sales %3.324.2 13.8%  
Current ratio x1.01.8 56.3%  
Inventory Days Days161100 160.4%  
Debtors Days Days31857 560.1%  
Net fixed assets Rs m3,67320,779 17.7%   
Share capital Rs m317252 125.4%   
"Free" reserves Rs m3,76124,499 15.4%   
Net worth Rs m4,07824,553 16.6%   
Long term debt Rs m1,6713,517 47.5%   
Total assets Rs m12,63339,595 31.9%  
Interest coverage x1.012.2 8.4%   
Debt to equity ratio x0.40.1 286.0%  
Sales to assets ratio x0.30.8 41.1%   
Return on assets %3.45.7 60.1%  
Return on equity %0.18.3 1.4%  
Return on capital %7.710.5 73.2%  
Exports to sales %22.948.6 47.1%   
Imports to sales %14.314.2 100.4%   
Exports (fob) Rs m96415,617 6.2%   
Imports (cif) Rs m6024,571 13.2%   
Fx inflow Rs m96415,617 6.2%   
Fx outflow Rs m6075,828 10.4%   
Net fx Rs m3579,790 3.6%   
CASH FLOW
From Operations Rs m1,3452,764 48.7%  
From Investments Rs m-2,256-1,432 157.5%  
From Financial Activity Rs m-1,200-1,591 75.4%  
Net Cashflow Rs m-2,111-259 815.6%  

Share Holding

Indian Promoters % 4.5 45.9 9.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.4 -  
FIIs % 1.4 25.3 5.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 17.4 540.8%  
Shareholders   20,807 36,892 56.4%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   PIRAMAL ENTERPRISES  NOVARTIS  PANACEA BIOTECH  MERCK LTD  GSK PHARMA  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Pharma & Realty Stocks Gain(09:30 am)

Asian share markets are mixed today. The Nikkei 225 is flat while the Hang Seng is down 0.1%. The Shanghai Composite is trading down by 1.1%.

Related Views on News

IPCA LABS Announces Quarterly Results (4QFY18); Net Profit Up 15.6%

May 30, 2018 | Updated on May 30, 2018

For the quarter ended March 2018, IPCA LABS has posted a net profit of Rs 513 m (up 15.6% YoY). Sales on the other hand came in at Rs 8 bn (up 17.6% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS